Xintela AB (publ) (STO:XINT)
0.1410
+0.0010 (0.71%)
Nov 20, 2026, 5:25 PM CET
Xintela AB Market Cap
Xintela AB has a market cap or net worth of 121.44 million as of November 20, 2026. It is the 40,026th most valuable company in the world and the 578th biggest in Sweden. Its market cap has decreased by 32.19% in one year.
Market Cap
121.44M
Enterprise Value
142.61M
Revenue
3.03M
Global Rank
Country Rank
#578 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 121.44M, an increase of 17.13%. That is a compound annual growth rate of 1.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 121.44M | -38.88% |
| Dec 30, 2025 | 198.68M | 5.85% |
| Dec 30, 2024 | 187.69M | 26.87% |
| Dec 29, 2023 | 147.94M | -1.74% |
| Dec 30, 2022 | 150.56M | -26.24% |
| Dec 30, 2021 | 204.12M | 2.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 171.13M |
| Elicera Therapeutics AB | 164.51M |
| Abera Bioscience AB | 140.62M |
| Diamyd Medical AB | 138.25M |
| BioInvent International AB | 137.53M |
| Simris Group AB (PUBL) | 137.49M |
| IRLAB Therapeutics AB | 108.41M |
| Alzinova AB | 97.82M |